Yuankai Shi

Chinese Academy of Medical Sciences - Peking Union Medical College

M.D.

Beijing 100021

China

Chinese Academy of Sciences (CAS) - Beijing Key Laboratory of Molecular Imaging

Beijing, 100190

China

National Cancer Center Hospital

Research Center for Cancer Prevention and Screenin

Tokyo

Japan

Chinese Academy of Medical Sciences

NO. 9, Dongdan Santiao

Beijing, Dongcheng District

China

SCHOLARLY PAPERS

3

DOWNLOADS

74

SSRN CITATIONS

2

CROSSREF CITATIONS

0

Scholarly Papers (3)

1.

Nivolumab versus Docetaxel in a Predominantly Chinese Patient Population with Previously Treated Advanced Non-Small-Cell Lung Cancer: CheckMate 078 Randomised Phase 3 Clinical Trial

Number of pages: 31 Posted: 25 Sep 2018
Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute, Shanghai Jiao Tong University (SJTU), Jilin Cancer Hospital, Tongji University - Department of Medical Oncology, Chinese Academy of Sciences (CAS), The Chinese University of Hong Kong (CUHK), Sun Yat-Sen University (SYSU), Guangdong Academy of Medical Sciences, Central South University - Hunan Cancer Hospital, Jiangsu Cancer Hospital - Department of Medical Oncology, Zhejiang Cancer Hospital, Leningrad Regional Clinical Hospital, Zhejiang University, Zhengzhou University - Henan Cancer Hospital, Sichuan University - West China Hospital, Central South University, Chinese Academy of Medical Sciences - Peking Union Medical College, Bristol-Myers Squibb, Bristol-Myers Squibb and Fudan University
Downloads 51 (411,556)
Citation 2

Abstract:

Loading...

nivolumab; PD-1 inhibitor; non-small-cell lung cancer; NSCLC; China; docetaxel; immunotherapy

2.

Efficacy and Safety of Sintilimab for Relapsed/Refractory Classic Hodgkin Lymphoma: A Multicentre, Single-Arm Phase II Study (ORIENT-1)

Number of pages: 118 Posted: 24 Sep 2018
Chinese Academy of Medical Sciences - Peking Union Medical College, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN and Peking Union Medical College, Chinese Academy of Medical Sciences, Institute of Hematology and Blood Diseases Hospital, State Key Laboratory of Experimental Hematology
Downloads 17 (576,903)

Abstract:

Loading...

PD-1, classic Hodgkin's Lymphoma, relapsed/refractory, ORIENT-1

3.

Effect of Surgical Resection on Survival in TP53-Mutated Diffuse Large B-Cell Lymphoma Patients

Number of pages: 17 Posted: 20 Dec 2019
Chinese Academy of Medical Sciences - Peking Union Medical College, Chinese Academy of Medical Sciences - Peking Union Medical College, Chinese Academy of Medical Sciences - Peking Union Medical College, Chinese Academy of Medical Sciences - Peking Union Medical College, Chinese Academy of Medical Sciences - Peking Union Medical College, Chinese Academy of Medical Sciences - Peking Union Medical College, Chinese Academy of Medical Sciences - Peking Union Medical College, Chinese Academy of Medical Sciences - Peking Union Medical College, Burning Rock Biotech, Geneplus-Beijing Institute, Geneplus-Beijing Institute, Chinese Academy of Medical Sciences - Peking Union Medical College and Chinese Academy of Medical Sciences - Peking Union Medical College
Downloads 6 (650,886)

Abstract:

Loading...